Comparison of Various Lipid Variables as Predictors of Coronary Heart Disease in Japanese Men and Women With Type 2 Diabetes

OBJECTIVE To determine the best lipid variable to predict coronary heart disease (CHD) in Japanese patients with type 2 diabetes. RESEARCH DESIGN AND METHODS Eligible Japanese men and women (1,771) aged 40–70 years with type 2 diabetes from 59 institutes nationwide were followed for a planned 8-year period. The performance of eight conventional lipid variables, i.e., total cholesterol (TC), LDL-cholesterol (LDLC), HDL-cholesterol (HDLC), triglycerides (TGs), non-HDLC, TC/HDLC ratio, LDLC/HDLC ratio, and TG/HDLC ratio, as predictors of incident CHD were evaluated by four methods: hazard ratio (HR) per one SD increment by multivariate Cox analysis, χ2 likelihood ratio test, area under the receiver operating characteristic curve (AUC), and tertile analysis. RESULTS Although all variables significantly predicted CHD events in men, non-HDLC (HR per one SD 1.78 [95% CI 1.43–2.21]; AUC 0.726) and TC/HDLC (HR 1.63 [1.36–1.95]; AUC 0.718) had the better predictive performances among the variables, including LDLC. In women, TGs (log-transformed; HR 1.72 [1.21–2.43]; AUC 0.708) were the best predictor according to results of tertile analysis (HR of the top tertile versus the bottom tertile 4.31 [1.53–12.16]). The associations with incident CHD were linear and continuous. CONCLUSIONS For Japanese diabetic men, non-HDLC and TC/HDLC were the best predictors, whereas TGs were most predictive for women. These findings, which included prominent sex differences, should be considered among clinical approaches to risk reduction among East Asians with diabetes.

[1]  Y. Yamasaki,et al.  Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). , 2011, The Journal of clinical endocrinology and metabolism.

[2]  S. Gudbjörnsdottir,et al.  Clinical Usefulness of Different Lipid Measures for Prediction of Coronary Heart Disease in Type 2 Diabetes , 2011, Diabetes Care.

[3]  R. Eckel,et al.  Triglycerides and Heart Disease: Still a Hypothesis? , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[4]  V. Ramjee,et al.  Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification: do the math. , 2011, Journal of the American College of Cardiology.

[5]  A. Sniderman,et al.  Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement. , 2011, Journal of clinical lipidology.

[6]  Moshe Levi,et al.  Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. , 2011, Circulation.

[7]  C. Furberg,et al.  A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk , 2011, Circulation. Cardiovascular quality and outcomes.

[8]  J. Kastelein,et al.  Lipid parameters for measuring risk of cardiovascular disease , 2011, Nature Reviews Cardiology.

[9]  A. Keech,et al.  Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes , 2010, Diabetologia.

[10]  C. Furberg,et al.  Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? , 2010, Journal of clinical lipidology.

[11]  C. Furberg,et al.  When is equal not equal? , 2010, Journal of clinical lipidology.

[12]  F. Azizi,et al.  Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study , 2010, Lipids in Health and Disease.

[13]  G. Landman,et al.  The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13) , 2009, PloS one.

[14]  V. Mohan,et al.  Blood lipid levels in relation to glucose status in seven populations of Asian origin without a prior history of diabetes: the DECODA study , 2009, Diabetes/metabolism research and reviews.

[15]  Weiping Jia,et al.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.

[16]  A. Mooradian Dyslipidemia in type 2 diabetes mellitus , 2009, Nature Clinical Practice Endocrinology &Metabolism.

[17]  G. Hitman,et al.  Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS) , 2009, Diabetologia.

[18]  J. Tuomilehto,et al.  Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: the DECODE Study. , 2008, Diabetes research and clinical practice.

[19]  A. Chait,et al.  Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies , 2008, The Lancet.

[20]  M. Pencina,et al.  Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. , 2007, JAMA.

[21]  I. Godsland,et al.  Mechanisms of Disease: lessons from ethnicity in the role of triglyceride metabolism in ischemic heart disease , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[22]  T. Tai,et al.  Independent association between triglycerides and coronary artery disease in Taiwanese type 2 diabetic patients. , 2006, International journal of cardiology.

[23]  A. Biggeri,et al.  Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study , 2006, Diabetologia.

[24]  S. Grundy,et al.  Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. , 2005, Diabetes care.

[25]  N. Cook,et al.  Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. , 2005, JAMA.

[26]  R. Holman,et al.  Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes. , 2005, Diabetes care.

[27]  A. Wägner,et al.  Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes. , 2005, Diabetes care.

[28]  J. Chan,et al.  Triglyceride predicts cardiovascular mortality and its relationship with glycaemia and obesity in Chinese type 2 diabetic patients , 2005, Diabetes/metabolism research and reviews.

[29]  J. Manson,et al.  Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes , 2004, Diabetologia.

[30]  Nader Rifai,et al.  Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. , 2004, Diabetes care.

[31]  L. Bouter,et al.  A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism—The Hoorn Study , 2003, Diabetologia.

[32]  R. Ozaki,et al.  Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes , 2003, Acta Diabetologica.

[33]  Y. Ohashi,et al.  Obesity and type 2 diabetes in Japanese patients , 2003, The Lancet.

[34]  D. Kunii,et al.  Validation of a Food Frequency Questionnaire Based on Food Groups for Estimating Individual Nutrient Intake , 2001 .

[35]  P. Bennett,et al.  Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity , 2001, Diabetologia.

[36]  D. Harats,et al.  Triglycerides and HDL Cholesterol Stars or second leads in diabetes? , 2009 .

[37]  齋藤 和美 Risk imparted by various parameters of smoking in Japanese men with type 2 diabetes on their development of microalbuminuria : analysis from the Tsukuba Kawai Diabetes Registry , 2007 .

[38]  M. Woodward,et al.  A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region. , 2005, Annals of epidemiology.

[39]  K. Jablonski,et al.  Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. , 2003, Diabetes care.